LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 49.63 | 27.76 | 2295 | 4818 | 0.4763 | 0.8102 | MN20160318_Q01 | I11 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 49.63 | 27.76 | 2322 | 4818 | 0.4819 | 0.8131 | MN20160318_Q01 | I11 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 49.63 | 27.76 | 320 | 4818 | 0.0664 | 0.3891 | MN20160318_Q01 | N13 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 49.63 | 27.76 | 2340 | 4818 | 0.4857 | 0.8150 | MN20160318_Q01 | N13 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 51.33 | 27.76 | 2413 | 5117 | 0.4716 | 0.8099 | MN20160318_Q01 | I11 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 51.33 | 27.76 | 2443 | 5117 | 0.4774 | 0.8129 | MN20160318_Q01 | I11 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 51.33 | 27.76 | 363 | 5117 | 0.0709 | 0.4072 | MN20160318_Q01 | N13 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 51.33 | 27.76 | 2448 | 5117 | 0.4784 | 0.8134 | MN20160318_Q01 | N13 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 53.04 | 27.76 | 2562 | 5365 | 0.4775 | 0.8145 | MN20160318_Q01 | I11 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 53.04 | 27.76 | 2593 | 5365 | 0.4833 | 0.8174 | MN20160318_Q01 | I11 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 53.04 | 27.76 | 380 | 5365 | 0.0708 | 0.4113 | MN20160318_Q01 | N13 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 53.04 | 27.76 | 2545 | 5365 | 0.4743 | 0.8129 | MN20160318_Q01 | N13 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 54.74 | 27.76 | 2636 | 5606 | 0.4702 | 0.8123 | MN20160318_Q01 | I11 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 54.74 | 27.76 | 2657 | 5606 | 0.4739 | 0.8142 | MN20160318_Q01 | I11 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 54.74 | 27.76 | 387 | 5606 | 0.0690 | 0.4107 | MN20160318_Q01 | N13 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 54.74 | 27.76 | 2539 | 5606 | 0.4529 | 0.8035 | MN20160318_Q01 | N13 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 56.45 | 27.76 | 2726 | 5745 | 0.4745 | 0.8153 | MN20160318_Q01 | I11 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 56.45 | 27.76 | 2740 | 5745 | 0.4769 | 0.8165 | MN20160318_Q01 | I11 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 56.45 | 27.76 | 386 | 5745 | 0.0672 | 0.4080 | MN20160318_Q01 | N13 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 56.45 | 27.76 | 2700 | 5745 | 0.4699 | 0.8130 | MN20160318_Q01 | N13 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 58.15 | 27.76 | 2865 | 5906 | 0.4851 | 0.8214 | MN20160318_Q01 | I11 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 58.15 | 27.76 | 2884 | 5906 | 0.4883 | 0.8229 | MN20160318_Q01 | I11 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 58.15 | 27.76 | 454 | 5906 | 0.0769 | 0.4353 | MN20160318_Q01 | N13 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 58.15 | 27.76 | 2872 | 5906 | 0.4862 | 0.8220 | MN20160318_Q01 | N13 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 59.85 | 27.76 | 2947 | 6062 | 0.4861 | 0.8227 | MN20160318_Q01 | I11 |